skip to main content

Case

Feb 14, 2014

Alcon Canada Inc. v. Cobalt Pharmaceuticals Company - 2014 FC 149

Featuring: Lindsay Neidrauer

This case involves an application for an order in the nature of prohibition to restrain the Minister of Health from issuing a Notice of Compliance under the Patented Medicines (Notice of Compliance) Regulations, to the respondent, Cobalt Pharmaceuticals Company [Cobalt], for approval to sell its generic version of an eye drop in which the active pharmaceutical ingredient is a 0.2% concentration of olopatadine.

Expertise

  • Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy